Podcasts about fnla

Listen in as our expert panel unpacks updated definitions of complicated vs. uncomplicated urinary tract infections, navigates antibiotic selection and duration, and shares the latest evidence-based strategies to stop recurrent UTIs in their tracks.Special guests:Dana Bowers, PharmD, BCPS, BCIDPAssociate ProfessorWashington State UniversityAkshith Dass, PharmD, MPH, BCPS, BCIDPAssistant Professor of Pharmacy PracticeNortheast Ohio Medical UniversityPharmacy Clinical Specialist Cleveland Clinic Mercy HospitalYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Craig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in April 2026.

"Les Roches Rouges" do francês Bruno Dumont é produzido pela portuguesa Rosa Filmes, a obra rodada essencialmente no sudeste francês, perto de Cannes, aborda temas de uma infância neste cenário de escarpas vermelhas, junto ao Mar Mediterrâneo. A película estreia na Quinzena dos cineastas. O produtor Joaquim Sapinho comentou à RFIa obra e este certame, em curso até 23 de Maio. Temos o privilégio de acolher de novo o Joaquim Sapinho da Rosa Filmes. Boa tarde! Bem vindo a mais uma edição do Festival de Cinema de Cannes. Estamos juntos para falar, nomeadamente do filme "Les Roches Rouges" de Bruno Dumont, com quem já tinham colaborado no passado. E é a Rosa Films, então produtora principal por detrás desta obra. Exacto. Nós tínhamo-nos conhecido no "L'Empire" e éramos co-produtores e quando chegou a oportunidade de fazer este filme, lá estávamos nós a querer colaborar e a ajudar. Mas as dificuldades de produção do filme obrigaram nos a nós a passar a produtores principais, porque todas as dificuldades de dinheiro e também de coordenação.... O realizador queria filmar este verão que passou. E, pela primeira vez na história das relações cinematográficas dos dois países, fez-se um filme em França com uma equipa inteiramente portuguesa. É muito ao contrário, habitualmente !   É sempre ao contrário. Portanto, foi uma coisa absolutamente mágica. Quando nós tomamos conta da produção, ficou uma arquitectura com filmagem em França. Filmagem em Portugal é filmagem em Itália. Mas toda a produção é portuguesa e os outros "partners" italianos, franceses e espanhóis ficaram apenas a ajudar. Portanto, foi uma experiência única. Nós já tínhamos vivido esta experiência com o filme do Magalhães, que tinha rodagens em Portugal.   No ano passado !   Com filmagens em Espanha e tinha filmagens nas Filipinas e também do lado espanhol. Tinha corrido tudo mal. Mandámos a equipa portuguesa depois nas Filipinas também correu mal. Mandámos também a equipa portuguesa. Portanto, aqui foi o mesmo. Foi só continuar esta estratégia, Se os outros não conseguem fazer, nós conseguimos. E então o filme é de facto rodado essencialmente no sul de França, na região onde nós nos encontramos um bocadinho, também em Itália, mas também em Portugal !? O filme também teve uma parte rodado em Portugal e é sempre este prazer de fazermos filmes cosmopolitas em que quer à produção quer às histórias, retratam esta Europa que nós amamos e não apenas a ideia de nacionalismos em que toda a gente está separada.   Bruno Dumont que já teve também projectos cá em Cannes no passado, já teve prémios cá, por exemplo, com "La vie de Jésus", "L'Humanité". Agora é um filme muito sobre a infância ou sobre uma parte do litoral do sul de França, onde a fotografia tem um papel absolutamente descomunal ! Eu acho que é só olhar à volta no sítio onde estamos a fazer esta conversa aqui em Cannes e ver este mar esmeralda. O que é que há de tão especial em Saint Raphaël ? É que para lá do mar esmeralda há umas rochas vermelhas. O filme em português chama se "Escarpas Vermelhas". Encontramos um título muito bonito em francês "Les Roches Rouges". Porque, digamos, é este espaço mágico, esta jóia que é a cor azul. Mas do lado da infância. Ou seja, é um filme sobre crescer, sobre como é que se cresce. Sobre as violências de crescer e sobre os amores também. É um filme... Sobre o bem e o mal? O bem e o mal., mas é um rapaz e uma rapariga que estão apaixonados. Fazem uma escapadela para Itália no comboio, mas têm só cinco anos. Portanto, o que é fascinante aqui é que nós somos humanos, logo a partir do momento em que nascemos e começamos a crescer apaixonados e a viver riscos. Portanto, é um filme, como direi? A dizer que a vida é apaixonante e que vale a pena correr riscos. E não lhe parece que eles eram, de facto, todos bastante precoces ? Teriam cerca de cinco anos. Efectivamente viajam juntos. Ele, de forma muito fácil, acaba por passar por cima do portão para ir ter com a namorada. Ele está muito determinado, não é o rapaz? O Géo está determinado ! Ele está determinado. E o que é bonito é que porque é que o filme também é "Les Roches Rouges" ? Não é apenas uma questão plástica. É porque essas rochas são umas rochas em que em França se faz uns saltos muito arriscados. E ele está sempre a demonstrar o seu valor saltando dessas rochas vermelhas. Saltos para mergulho ! Para mergulhar e, portanto, é um filme que defende a ideia de viver como uma ideia apaixonada. É uma ideia em que não podemos, digamos, estar esmagados pelo medo para viver, mas de que é possível viver com intensidade. E aqui o americano Carlos Alfonso Coral deve ter tido um papel preponderante em relação à questão da imagem, de captar este litoral e estas escarpas vermelhas? Ele é um director muito sensível, muito poético, tem trabalhado essencialmente com o Roberto Minervino, que tem tido também os filmes aqui em Cannes. Mas e vive neste momento em Los Angeles. Ele é do México e, claro, ficou. Nunca tinha estado aqui na Côte d'Azur. E estas cores e esta dramaticidade do filme, evidentemente, permitiram-lhe a ele também responder, dando estas cores e essa dramaticidade ao cinema. Que sabor tem, então, esta estréia aqui na Quinzena dos Cineastas com este filme ? A Rosa Filmes, desde 2016 tem sempre um filme seleccionado em Cannes. Nem sei se haverá outra produtora no mundo ? Desde 2016, portanto vamos para 11 anos, não é? Todos os anos sempre um filme, e já tivemos vários filmes em que éramos nós os produtores principais, mas estes dois últimos também, quer com o Magalhães, com o Gael Garcia Bernal, realizado pelo Lav Diaz, quer agora com este filme do Bruno Dumont isto se repete. Portanto, não há outra palavra. É um prazer ! Eu acho que Cannes é um festival em que a paixão pelo cinema se sobrepõe a tudo, a todas as outras questões. E toda a gente se sente atraída por isto e, portanto, é o sítio certo para mostrar os filmes que nós fazemos. E a nossa imagem de marca também está ligada a Cannes. Então e esta septuagésima nona edição do Festival interessa-o ? Se sim, que mais lhe interessa aqui neste certame? Eu acho que há um realizador francês extraordinário. Eu acho que é o grande jovem realizador francês que é o Arthur Harari e é a sua terceira longa metragem. Também ganhou o Oscar de melhor Argumento no ano passado. Está em competição nas longas metragens, na selecção principal ! Sim, na selecção principal, nas longas metragens. E é esse filme de que foi argumentista ganhou também a Palma de Ouro há dois anos. Eu acho que o grande realizador francês agora da Nova geração é este filme. Será o filme mais entusiasmante para ver. Muitos filmes franceses, precisamente na competição, Se calhar mais do que é habitual, portanto, também se calhar provar a boa forma do cinema hexagonal, neste momento, o que é que acha ? Muitos filmes franceses e também muitos actores e actrizes franceses nos filmes estrangeiros. Exactamente. Até em filmes estrangeiros, japoneses, austríacos ! Portanto, é uma grande... Eu acho que a França é o centro do cinema europeu e pouco a pouco está a tornar-se também o centro do cinema, porque a gente vê que os Óscares estão a copiar o modelo. Este modelo europeu de Cannes e portanto temos todos que nos adaptar uns aos outros. Mas dá me a impressão que este nosso modelo do cinema europeu que tem como centro a França e Cannes, é o que está mais vivo neste momento. E finalmente, o cinema português. No meio desta dinâmica toda, como é que o vê nesta altura? Eu bem sei que é sempre complicado. É sempre a mesma dificuldade de acesso a financiamentos. No entanto, surgem sempre propostas que vão singrando internacionalmente, não é?   Dou-lhe o meu exemplo vou filmar este ano em África. Fazer um filme sobre Angola. Eu acho que vai ser o primeiro filme em que um português vai fazer o ponto de vista do outro ponto de vista dos movimentos de independência e não um filme nostálgico sobre "Ah, que pena, Portugal perdeu África". Há uns filmes que são mais engraçados a falar desse assunto, outros mais dramáticos, outros mais melancólicos. Eu não estou interessado nisso. Estou interessado é o "como é que foi este conflito e qual é o ponto de vista do outro" ? E, portanto, vou fazer um filme pela primeira vez sobre como é que os movimentos de independência se confrontavam connosco. Mas o meu ponto de vista ainda é mais complexo. Esse confronto connosco era de portugueses com portugueses. Toda a gente tinha o mesmo bilhete de identidade. Portanto, tentar ter um ponto de vista que ajude a que Portugal possa viver com o seu passado, de outra maneira.   E vão rodar também na África Equatorial, nomeadamente. A dinâmica do cinema português está em cada filme que é feito. E de quem é o argumento ? É meu. É uma história extraordinária que eu descobri, já ando a preparar o filme há cerca de dez anos, porque descubro um dia um folheto em francês sobre cinco mulheres que tinham sido presas. Não pelos portugueses lá em Angola, mas sim pela UPA, que era um movimento rival que depois se transformou no FNLA. E essas mulheres são presas e depois são mortas. Portanto, é uma tragédia enorme. E, portanto, é a primeira vez que acontece. Cinco mulheres entram na guerrilha e entram. Vêm do Congo, no quadro do MPLA, entram em Angola e depois vão ser atacadas pela UPA e vão ser mortas. E portanto é contar esta tragédia do que é que estava a acontecer de complexo dentro dos movimentos de libertação. Quando eu descobri estas mulheres, a lider chama-se Deolinda Rodrigues. Ela é actualmente o símbolo da mulher angolana. Há um dia feriado que é o dia em que ela foi morta, esta Deolinda Rodrigues. E eu, desde que conheci esta personagem, esta pessoa, este fantasma, tomou posse de mim e passei a viver obcecado com esta história. E, portanto, filmá-la. E também libertar me deste fantasma.

Listen in as our expert panel covers the latest evidence on using menopausal hormone therapy and nonhormonal options for treatment of vasomotor symptoms (hot flashes, etc). You'll also hear experts discuss treatments for genitourinary symptoms (vaginal dryness, etc) as well as low libido and brain fog.Special guests:Veronica Vernon, PharmD, BCPS, BCACP, MSCP, FAPhA Associate Professor, Chair of Pharmacy PracticeButler UniversitySarah M. Westberg, PharmD, FCCP, BCPSAssociate Dean for Professional Affairs Professor, College of PharmacyUniversity of MinnesotaYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Andrea Darby-Stewart, MDAssociate Director, Honor Health Family Medicine Residency ProgramClinical Professor of Family, Community & Occupational MedicineThe University of Arizona College of Medicine – PhoenixCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in March 2026.

Listen in as our expert panel tackles real-world questions about GLP-1 agonists, from starting them and setting expectations with patients to strategies for switching agents. You'll also hear them review key considerations to limit muscle loss with GLP-1 agonist use and discuss why some patients hit a plateau or don't respond to GLP-1 agonists.Special guests:Jennifer N. Clements, PharmD, FCCP, FADCES, BCPS, BCACP, CDCES, BC-ADMClinical Professor and Director of Pharmacy EducationUniversity of South Carolina College of PharmacyJennifer M. Trujillo, PharmD, BCPS, FCCP, CDCES, BC-ADMProfessor and the Associate Dean for EducationUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical SciencesPanelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityFor the purposes of disclosure Dr. Jennifer Clements reports relevant financial relationships with Novo Nordisk (Ozempic, Rybelsus), Eli Lilly (Zepbound, tirzepatide) [speakers bureau].The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in February 2026. 

Irão: Moçambicanos e angolanos pedem neutralidade de Maputo e Luanda. Maputo já terá manifestado solidariedade aos Emirados Árabes Unidos. Há crise na FNLA: militantes acusam a liderança de falta de transparência.

Qual o significado por trás da comemoração dos 50 anos da independência de Angola?No episódio #107 as petianas Beatryz Chiarotto e Nathália Athanazio recebem o professor da UFF Marcelo Bittencourt para tratar dos 50 anos da independência de Angola. Essa conversa mantém nosso compromisso em ampliar os eixos temáticos do petcast e compreender de maneira mais complexa o continente africano. O episódio aprofunda-se no contexto do país antes da independência e os principais movimentos de resistência como o MPLA, FNLA e a UNITA. Além disso, abordamos os desafios da memória para as novas gerações, que não vivenciaram a luta armada e a presença colonial.

Listen in as our expert panel reviews important concepts behind antimicrobial stewardship along with tips to help limit unnecessary antimicrobial use.Special guests:Madeline King, PharmD, MPH, BCIDPCo-Director, Outpatient Antimicrobial StewardshipCooper University Health CareAssistant Professor of MedicineCooper Medical School at Rowan UniversityMichael A. Deaney, PharmD, AAHIVPInfectious Diseases Clinical Pharmacy SpecialistDenver Health & Hospital AuthorityYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science University For the purposes of disclosure, Dr. Madeline King reports a relevant financial relationship with Shionogi (speakers bureau for cefiderocol).The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in January 2026.Use code mt1026 at checkout for 10% off a new or upgraded subscription.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources related to this podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Toolbox: Antimicrobial StewardshipAlgorithm: Investigating Possible Drug AllergyCE Course: Implementing Rapid Diagnostic TestingChart: Antibiotic Therapy: When Are Shorter Courses Better?Send a text*****

In this bonus episode of Medication Talk, join us for an extended conversation with our expert panel as we go beyond the original webinar and podcast episode to share brand-new insights and never-before-heard content.Listen in as we dive deeper into practical strategies for starting conversations with patients about tobacco use, plus additional perspectives on nicotine's effects and health risks, emerging therapies, non-drug approaches, and how to make smoking cessation part of everyday pharmacy practice.**No CE Credit is available for this bonus episode.**Special guest:Robin Corelli, PharmD, CTTS, FCSHPProfessor of Clinical PharmacySchool of PharmacyUniversity of California, San FranciscoYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in November 2025. Plus, it includes brand-new insights and never-before-heard content.The clinical resources related to this podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Chart: Smoking Cessation Drug TherapyFAQ: E-Cigarettes and VapingArticle: Help Patients Send Their Vaping Habits Up in SmokeUse code mt1026 at checkout for 10% off a new or upgraded subscription.Send us a textEmail us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. Learn more about our product offerings at trchealthcare.com.

Listen in as our expert panel discusses evidence-based approaches to help patients quit smoking, vaping, and using other nicotine products. You'll gain practical insights on medication selection, combination strategies, and tailored approaches for helping patients break free from nicotine addiction.Special guest:Robin Corelli, PharmD, CTTS, FCSHPProfessor of Clinical PharmacySchool of PharmacyUniversity of California, San FranciscoYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in November 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources related to this podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Chart: Smoking Cessation Drug TherapyFAQ: E-Cigarettes and VapingChart: Dos and Don'ts With PatchesArticle: Help Patients Send Their Vaping Habits Up in Smoke Use code mt1026 at checkout for 10% off a new or upgraded subscription.Send us a textEmail us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. Learn more about our product offerings at trchealthcare.com.

Listen in as our expert panel discusses critical aspects of managing patients on oral cancer therapies. Our experts review tips for optimizing patient care and share best practices for handling these specialized medications.Special guests:Jill Cassaday, BPharm, PharmD, BCPS, BCOPClinical Pharmacist Specialist – Multiple MyelomaBanner MD Anderson Cancer CenterSamuel Snowaert, PharmD, BCOP, MBAClinical Oncology Pharmacist Pharmacists Optimizing Oncology Care Excellence in Michigan (POEM)Covenant Cancer Care CenterLisa Thompson, PharmD, BCOP, CPPSClinical Pharmacy Specialist in Oncology Kaiser Permanente ColoradoYou'll also hear practical advice from TRC's Editorial Advisory Board member:Craig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in October 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources related to this podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: FAQ: Specialty MedsChart: Guide for Helping Patients Afford Their MedicationsChart: Drug Interactions: Cytochrome P450 (CYP), P-glycoprotein, and MoreToolbox: Medication Adherence StrategiesAlgorithm: Redosing Oral Medications After VomitingUse code mt1025 at checkout for 10% off a new or upgraded subscription.Send us a textEmail us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. Learn more about our product offerings at trchealthcare.com.

No dia 11 de Novembro de 1975 foi proclamada a independência de Angola por Agostinho Neto, do MPLA, por Holden Roberto, da FNLA, e por Jonas Savimbi, da UNITA. Nesse mesmo dia começava a guerra civilSee omnystudio.com/listener for privacy information.

Na Guiné-Bissau, o Supremo Tribunal de Justiça não incluiu Domingos Simões Pereira na lista definitiva de candidatos às eleições presidenciais. Em Angola, o Presidente João Lourenço anunciou a atribuição de medalhas comemorativas dos 50 anos da Independência a Jonas Savimbi e Holden Roberto, depois de muitas críticas pela ausência destes nomes nas listas de condecorações. Em Moçambique, é o primeiro aniversário do duplo homicídio de Elvino Dias e Paulo Guambe e em Cabo Verde festeja-se o apuramento para o Mundial de Futebol de 2026. Na Guiné-Bissau, o Supremo Tribunal de Justiça não incluiu Domingos Simões Pereira, principal líder da oposição, na lista definitiva de candidatos à presidência da República nas eleições gerais de 23 de Novembro. A candidatura da Plataforma Aliança Inclusiva (PAI) - Terra Ranka, liderada pelo PAIGC, às eleições legislativas também não foi aceite. Esta será a primeira vez que o PAIGC, histórico partido da libertação, fica de fora de uma corrida eleitoral na Guiné-Bissau. A lista definitiva das candidaturas às eleições presidenciais foi divulgada esta sexta-feira e Domingos Simões Pereira disse à RFI que “a intenção clara” é afastá-lo do escrutínio e acusou o actual Presidente Umaro Sissoco Embaló de ter “medo de o enfrentar nas urnas”. Na terça-feira, jornalistas de três rádios locais de Bissau, nomeadamente a Capital FM, foram impedidos de cobrir a conferência de imprensa do Supremo Tribunal de Justiça quando este divulgou a lista provisória das candidaturas validadas. Tiago Seide, director da capital FM, disse à RFI que não foi apresentada nenhuma justificação. Por outro lado, na segunda-feira, a Ordem dos Advogados da Guiné-Bissau condenou com veemência o rapto e o espancamento de Luís Vaz Martins, antigo líder da Liga Guineense de Direitos Humanos e actual presidente da comissão de direitos humanos da Ordem dos Advogados da Guiné-Bissau. Em Angola, na quarta-feira, o Presidente João Lourenço anunciou, na mensagem sobre o Estado da Nação, na Assembleia Nacional, que os signatários dos Acordos de Alvor, incluindo Jonas Savimbi e Holden Roberto, os fundadores da UNITA e da FNLA, vão ser lembrados com a medalha comemorativa dos 50 anos da Independência de Angola. O gesto - disse o Presidente - é enquadrado no espírito de "perdão e reconciliação”. Esta decisão surge após muitas críticas pela ausência destes nomes nas listas de condecorações já atribuídas no âmbito dos 50 anos da independência nacional. O presidente da UNITA, Adalberto Costa Júnior, lembrou que foi um “processo muito longo”, marcado pela rejeição na Assembleia do “reconhecimento aos pais da nação” e  “uma série imensa de não aceitações individuais de condecorações”. Além disso, Adalberto Costa Júnior sublinha que Jonas Savimbi e Holden Roberto devem ser reconhecidos “por mérito” e não por perdão. Por outro lado, Nimi A Simbi, presidente da FNLA, considerou a distinção de Holden Roberto como um reconhecimento do papel do partido “para a libertação de Angola”. Na terça-feira, Angola foi eleita membro do Conselho de Direitos Humanos das Nações Unidas para o triénio 2026-2028. As autoridades angolanas referem que esta eleição resulta do “reconhecimento dos avanços institucionais e do compromisso do país com a dignidade humana”. Porém, há vozes que denunciam que "o país não respeita os direitos humanos". Esta sexta-feira, em Luanda, um grupo e defensores dos direitos humanos convocou uma vigília para apelar à libertação de activistas detidos em Julho quando se manifestavam contra o aumento do preço do combustível e dos transportes. Em Moçambique, este sábado, 18 de Outubro, marca o primeiro aniversário do duplo homicídio de Elvino Dias e Paulo Guambe, algo que desencadeou meses de protestos em Moçambique depois das eleições gerais de Outubro de 2024. Agora, o ex-candidato presidencial Venâncio Mondlane anunciou que, até Dezembro, estará em actividade uma fundação inspirada em Elvino Dias, conhecido como “advogado do povo”. Venâncio Mondlane responsabilizou os "esquadrões da morte" pelo duplo homicídio dos seus apoiantes. No distrito de Memba, na província costeira de Nampula, no norte de Moçambique, a população continua com medo depois dos ataques terroristas de 30 de Setembro e 3 Outubro, contou o administrador do distrito, Manuel Cintura.  Em Cabo Verde, segunda-feira foi dia de festa com o apuramento inédito da selecção para o Mundial de Futebol. Os Tubarões Azuis venceram o Essuatíni por três a zero no Estádio Nacional, na cidade da Praia. O selecionador cabo-verdiano, Pedro Leitão Brito, connhecido por “Bubista”, descreveu a união entre jogadores como factor essencial para o apuramento. Em São Tomé e Príncipe, o grupo HBD do empresário Mark Shuttleworth anunciou que vai suspender o seu  investimento na ilha do Príncipe. Os governos central e regional mostraram vontade de reverter a situação. Em Madagáscar, esta sexta-feira tomou posse como Presidente o coronel Michael Randrianirina, comandante de uma unidade de elite, três dias depois de ter anunciado que as forças armadas locais iam tomar conta do país e após três semanas de protestos contra o governo. O golpe militar foi condenado pelas Nações Unidas e levou à exclusão provisória de Madagáscar da União Africana. O presidente deposto, Andry Rajoelina, está em paradeiro desconhecido, após ter fugido da ilha por temer pela própria vida durante a rebelião. Porém, o coronel Michael Randrianirina rejeita falar em golpe de Estado. O líder da oposição queniana, Raila Odinga, morreu na quarta-feira, aos 80 anos, na Índia, onde recebia cuidados médicos. Odinga marcou profundamente a história política do Quénia. Foi várias vezes candidato à presidência e foi primeiro-ministro entre 2008 e 2013. No funeral de Estado, esta sexta-feira, dezenas de pessoas ficaram feridas num movimento de pânico, um dia depois de três pessoas terem morrido quando as forças de segurança abriram fogo contra um estádio onde decorria uma homenagem a Raila Odinga.

Listen in as we discuss considerations, challenges, and strategies related to the use and switching of biosimilars in clinical practice.  You'll hear communication tips to address patient and prescriber concerns as well as operational considerations for integrating biosimilars into practice.  Special guests:Bharati Bhardwaja, PharmD, BCPS, LSSBBRheumatology Clinical Pharmacy SpecialistKaiser Permanente ColoradoMegan May, PharmD, BCOP, FHOPA, FAPOClinical Oncology Pharmacy SpecialistBaptist Health Lexington/Hamburg Cancer Care CenterYou'll also hear practical advice from TRC's Editorial Advisory Board member:Craig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityFor the purposes of disclosure, Dr. Megan May reports relevant financial relationships [lung cancer] with Amgen, AstraZeneca, Pharmacosmos (speakers bureau). The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in August 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: FAQ: Facts About BiosimilarsChart: Comparison of Insulins (United States)Chart: Biologics for Rheumatoid ArthritisChart: Biologics for Crohn's DiseaseUse code mt1025 at checkout for 10% off a new subscription.Send us a text****

Listen in as our expert panel discusses the latest recommendations for managing medications after heart attacks and other cardiac events. You'll hear our panelists review which antiplatelets to use, the optimal blood pressure meds, and the role of statin and non-statin cholesterol meds.Special guests:Danielle Blais, PharmD, FCCP, BCCP, BCPSCardiology Lead Specialty Practice PharmacistRichard M. Ross Heart HospitalThe Ohio State University Wexner Medical CenterJoel C. Marrs, PharmD, MPH., BCACP, BCCP, BCPS, FAHA, FASHP, FCCP, FNLAProfessor and Coordinator of Clinical OutreachThe University of Tennessee Health Science CenterDepartment of Clinical Pharmacy & Translational ScienceYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Andrea Darby-Stewart, MDAssociate Director, Honor Health Family Medicine Residency ProgramClinical Professor of Family, Community & Occupational MedicineThe University of Arizona College of Medicine – PhoenixCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in July 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Dual Antiplatelet Therapy for Coronary Artery DiseaseComparison of Oral Beta-BlockersAngiotensin Receptor Blockers and Angiotensin-Converting Enzyme InhibitorsCholesterol Guidelines (United States)Non-Statin Lipid-Lowering AgentsSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Angola pretende canalizar mais de sete milhões de dólares norte-americanos num jogo amigável com a selecção da Argentina, previsto para 11 de Novembro, no âmbito das celebrações dos 50 anos da Independência Nacional. As ONG's angolanas criticam a iniciativa devido ao actual contexto socio-económico que o país atravessa.  Angola pretende canalizar mais de sete milhões de dólares norte-americanos num jogo amistoso com a selecção da Argentina, previsto para 11 de Novembro, no âmbito das celebrações dos 50 anos da Independência Nacional. Os Albicelestes já confirmaram o jogo amigável com os Palancas Negras. Entretanto, quatro ONG´S angolanas criticam a iniciativa e solicitam o cancelamento do jogo, devido ao actual contexto socio-económico que o país atravessa.  Por apenas 90 minutos de jogo, a selecção argentina de futebol pode facturar, em Novembro deste ano, cerca de 11 milhões de dólares numa partida amigável, a decorrer em Luanda, com a selecção angolana de futebol, no dia do jubileu da Independência de Angola. O montante, a ser gasto, está a gerar críticas pela sociedade angolana, que ainda acredita que a Argentina possa desistir do convite da Federação Angolana de Futebol (FAF).  É o caso de Serra Bango, líder da Associação Justiça, Paz e Democracia (AJPD), que diz ser uma vergonha Angola gastar tanto dinheiro num jogo, quando o país se encontra mergulhado numa crise social e económica sem precedentes.  O nosso objectivo é, exactamente, chamar a atenção aos jogadores da selecção argentina, sobretudo ao Messi, porque eles têm uma visibilidade universal. A nossa chamada de atenção é no sentido de que eles se solidarizem com o sofrimento por que passam os cidadãos angolanos: a fome, a miséria, a nudez, o desemprego, falta de educação, de escolas. Nós temos problemas ainda de cólera, paludismo, saneamento básico. Temos problemas de saúde como a febre tifóide, por falta de água potável, por quase todo o país.  E associado a isso, infelizmente, ocorreu neste espaço de tempo aquelas execuções sumárias que já têm ocorrido várias vezes e têm sido denunciadas por vários outros activistas das execuções sumárias que ocorrem em Angola. Face a isso e face ao volume financeiro que se quer despender para esta partida de futebol, não temos certeza se serão apenas os 6 milhões de dólares que poderão ser revertidos para outras situações aqui em Angola. Nós apelamos à solidariedade destes jogadores, no sentido de recusarem esta vinda, este convite para jogarem com Angola. Porque nós temos assistido a nível da África - infelizmente Angola não escapou - preferem desembolsar várias somas de dinheiro para visitas momentâneas de ilustres figuras a nível do topo universal e o povo angolano vive na indigência. A Friends Of Angola, a Pro Bono Angola e a AJPD são subscritoras de uma carta enviada à Federação Argentina de Futebol e a Lionel Messi, cujo teor tem a ver com o cancelamento do jogo.  Florindo Chivucute, presidente da Friends Of Angola, entende que a selecção da Argentina antes de aceitar o convite de Angola, deveria lembrar-se do movimento de protesto de um grupo de mulheres que exigia a localização de seus filhos desaparecidos durante a ditadura militar argentina.  Esta decisão ficará na história, porque os argentinos sabem muito bem qual é as consequências de uma ditadura. É importante aqui lembrar das mães da Praça de Maio que começaram as suas marchas em 1977, que representam um dos maiores símbolos mundiais de resistência contra a violência de Estado e o desaparecimento forçado de pessoas durante a ditadura militar argentina que durou de 1976 a 1983. As mães  da Praça de Maio até hoje continuam a se reunir, todas as quintas-feiras, na Praça de Maio, lembrando ao mundo que não se pode esquecer do passado. É uma luta que simboliza a luta pela memória, pela verdade e pela justiça e é isso que nós esperávamos que a selecção da Argentina fizesse, mas, infelizmente, não fez. Serra Bango esclarece que a sociedade civil angolana não está contra o jogo, mas contra os gastos milionários a serem aplicados pelo Governo. A nossa carta apresenta dados, números que foram pesquisados, quem quiser desmenti-los, que apresentem outros números e outros dados diferentes. Por outro lado, nós não estamos contra uma partida de futebol. Angola pode jogar, aliás, é bom que a celebração dos 50 anos seja feita. Mas aqui há outro elemento. É que o partido no poder e o executivo querem fazer da celebração dos 50 anos só a sua actividade, particularmente não está a envolver os angolanos. Nem os outros movimentos. Mas a independência não foi conquistada só pelo MPLA.  Por outro lado, há um elemento importante. Seria interessante que a selecção de Angola ou a República de Angola, o nosso país, ao invés de convidar a selecção argentina, convidasse quatro selecções africanas, o valor não seria tanto. Estas equipas que eventualmente vão participar no CAN, teriam interesse também em ter jogos de preparação e aproveitariam a selecção de Angola a preparar-se com mais duas ou três equipas.  Para a independência de Angola participaram outros estados africanos. O Congo Democrático, ex-Zaire, o MPLA encontrou guarida no Congo, a FNLA quase que foi fundada no Congo, a UNITA encontrou guarida no Congo… por isso, é que temos angolanos refugiados no Congo e na Zâmbia.  A Zâmbia foi o país que abriu as portas para esses movimentos,  inserindo-se nos vários contactos internacionais, a nível da antiga OUA, actualmente União Africana. Convidem estes países! A selecção da Argentina confirmou a vinda a Luanda. Mas, apesar disso, o responsável da Friends Of Angola ainda acha que os argentinos podem vir a recuar na decisão, em solidariedade com milhares de crianças angolanas sem escolas.  Apesar da equipa nacional da Argentina ter confirmado o jogo, há sinais de que o jogador Lionel Messi não irá participar nesse jogo, que para nós já é um ganho, e espero que não participe mesmo. Fizemos um apelo de novo à selecção da Argentina, para que, de facto, repensem a decisão, ainda vão a tempo, que não manchem a sua dignidade por causa de 6, 11 ou 20 milhões de dólares. Ainda há tempo de eles poderem recuar nesta decisão. Este dinheiro deveria sim ser usado para dar oportunidade a crianças, centenas de crianças, em Luanda, e em todo o país, para ir à escola pela primeira vez. Nós temos centenas de crianças que estão fora do ensino todos os anos, porque, segundo as autoridades locais, não há condições para essas crianças poderem atender a escola pela primeira vez, não há escolas suficientes. Era nesse sentido que nós gostaríamos mais uma vez apelar à equipa da Argentina e ao próprio executivo angolano que não realize este evento, que use este dinheiro para melhorar a vida dos angolanos, porque isto é o que os angolanos querem. Para as organizações da sociedade civil, o Governo, liderado pelo MPLA, quer proporcionar uma operação de charme com jogo, no sentido de branquear a imagem do Presidente aos olhos do mundo, tendo em conta a oposição interna que tem na sua formação política e a falta de soluções concretas e imediatas para o país.

Angola: Polícia acusa mulher executada por agentes policiais de ter estado envolvida nos tumultos e pilhagens. Governo angolano proibe protestos em Cabinda. A Conferência Episcopal de Angola e São Tomé (CEAST) exige a mesma consideração dada a Agostinho Neto para outros nacionalistas da oposição. Ucrânia: PR apela aos seus parceiros a "forçar Moscovo a fazer a paz" e ter "negociações a sério".

Listen in as our expert panel discusses practical considerations for starting and optimizing antidepressants for treating depression and anxiety.  You'll listen to panelists cover various aspects of antidepressant use, such as serotonin syndrome, QT prolongation, and weight gain concerns.Special guest(s):Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP Director of Pharmacy and Residency Programs, New York State Office of Mental Health State University of New York at Buffalo School of Pharmacy and Pharmaceutical Sciences Sarah E. Grady, PharmD, BCPS, BCPPProfessor, Drake University College of Pharmacy and Health SciencesClinical Pharmacist, Inpatient Behavioral Health Unit, Broadlawns Medical CenterYou'll also hear practical advice from TRC's Editorial Advisory Board member:Craig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in May 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources related to this podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights.Clinical Resources: Choosing AntidepressantsSwitching AntidepressantsCombining and Augmenting AntidepressantsPharmacotherapy of Anxiety Disorders in AdultsSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Listen in as our expert panel discusses medications for the treatment of Alzheimer dementia.  They'll review the risks and benefits of cholinesterase inhibitors, memantine, and the anti-amyloid monoclonal antibodies.  And you'll hear strategies for managing behavioral and psychological symptoms of dementia.   Special guests:Tatyana Gurvich, PharmD, BCGP, APhAssociate Professor of Clinical PharmacyMann USC School of PharmacyUCI Senior Health CenterCandace Pierce, DNP, RN, CNE, COINurse Educator, Nurse Planner, and Healthcare LeaderColibri HealthcareDarlene Moyer, MD, FAAFPAssociate Director, HonorHealth Family Medicine Residency ProgramAssociate Professor of Clinical Practice – SOMME – Arizona State UniversityClinical Associate Professor – University of Arizona College of Medicine - PhoenixYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in April 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: FAQ - Alzheimer Dementia Pharmacotherapy Chart – Pharmacotherapy of Dementia BehaviorsChart - Drugs with Anticholinergic ActivityChart - Send us a textCheck out our NEW podcasts.Rumor vs TruthYour trusted source for facts... where we dissect the evidence behind risky rumors and reveal clinical truths.Clinical CapsulesTRC editors break down the most impactful clinical developments - giving you clear, actionable takeaways in just minutes.If you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Health coaching requires personalized recommendations, multiple conversations, and shared decision-making. Learn about the 3 Es and 3 Ps of coaching, motivational strategies, and the importance of self-care. Guest Erum Jiva, DNP, ARNP-BC, CLS, FNLA, FPCNA.Related PCNA resource:Behavior Change Mini-Certificate: https://pcna.net/online-course/behavior-change-mini-certificate/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Listen in as our expert panel discusses medications for management of opioid use disorder. They'll review strategies to optimize buprenorphine use and clarify the role of methadone and naltrexone.Special guest:Tyler J. Varisco, PharmD, PhDUniversity of Houston College of Pharmacy Assistant Professor, Department of Pharmaceutical Health Outcomes and PolicyAssistant Director, The PREMIER CenterYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Clinical Associate Professor of Family Medicine for the Prisma Health/USC School of Medicine Greenville Family Medicine Residency Program at the University of South Carolina School of Medicine, GreenvilleCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science UniversityFor the purposes of disclosure, Dr. Varisco reports a financial relationship [cardiology, inflammatory bowel disease] with HEALIX Infusion Therapy (research consultant).The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in March 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: FAQ: Management of Opioid Use DisorderChart: Treatment of Opioid WithdrawalFAQ: Treatment of Acute Pain in Opioid Use DisorderFAQ: Meds for Opioid OverdoseSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this episode of Geriatric Pharmacy Focus, we welcome back Dr. Thomas Dayspring for an in-depth discussion on lipoprotein(a). We explore what it is, how to test for it, available treatment options, and the pharmacist's role in raising awareness for this genetic cardiovascular risk factor. The information presented in this podcast is intended for general knowledge and educational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment. We are not liable for any actions taken or not taken based on the information provided in this podcast Tamara Ruggles, PharmD, BCGP, FASCP:  www.linkedin.com/in/tamara-ruggles-491882251 Thomas (Dr. Lipid) Dayspring, MD FACP, FNLA (guest):  linkedin.com/in/thomas-dayspring-md-facp-fnla-3aaa876 Family Heart Foundation:  familyheart.org

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education. Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence Educational Objectives Examine best practices for optimizing medication adherence and treatment initiation in hypercholesterolemia management Explain patient education and counseling for managing hypercholesteremia Faculty: Joseph Saseen, PharmD, BCPS, BCACP, CLS Professor and Associate Dean for Clinical Affairs University of Colorado Anschutz Medical Campus Skaggs School of Pharmacy and Pharmaceutical Sciences Aurora, Colorado   Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Executive Director, Ambulatory Pharmacy Services Grady Health System Atlanta, Georgia Joseph Saseen, PharmD, BCPS, BCACP, CLS, has the following financial relationships with commercial interests to disclose: Other Support (Lipid Monitoring Committee): Amgen (VESALIUS and OCEAN(a))   Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA, has the following financial relationships with commercial interests to disclose: Grant/Research Support: Novartis Consultant: Novartis, Regeneron   Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-9999-25-069-H01-P. The activity is available for CE credit through March 31, 2026.   This activity is jointly provided by the University of Connecticut School of Pharmacy–Storrs and Pharmacy Times Continuing Education™, and is supported by an educational grant from Novartis Pharmaceuticals Corporation.   Please follow the link below to access this activity on PTCE and claim CE credit: www.pharmacytimes.org/hyperlipidemiapodcast

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education. Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence Educational Objectives Examine best practices for optimizing medication adherence and treatment initiation in hypercholesterolemia management Explain patient education and counseling for managing hypercholesteremia Faculty: Joseph Saseen, PharmD, BCPS, BCACP, CLS Professor and Associate Dean for Clinical Affairs University of Colorado Anschutz Medical Campus Skaggs School of Pharmacy and Pharmaceutical Sciences Aurora, Colorado   Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Executive Director, Ambulatory Pharmacy Services Grady Health System Atlanta, Georgia Joseph Saseen, PharmD, BCPS, BCACP, CLS, has the following financial relationships with commercial interests to disclose: Other Support (Lipid Monitoring Committee): Amgen (VESALIUS and OCEAN(a))   Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA, has the following financial relationships with commercial interests to disclose: Grant/Research Support: Novartis Consultant: Novartis, Regeneron   Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-9999-25-069-H01-P. The activity is available for CE credit through March 31, 2026.   This activity is jointly provided by the University of Connecticut School of Pharmacy–Storrs and Pharmacy Times Continuing Education™, and is supported by an educational grant from Novartis Pharmaceuticals Corporation.   Please follow the link below to access this activity on PTCE and claim CE credit: www.pharmacytimes.org/hyperlipidemiapodcast

In this episode, listen in as our expert panel digs into identifying and treating acute bronchitis and community-acquired pneumonia. They'll discuss when antibiotics are appropriate, which antibiotics to use, and other management tips.You'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Program Director for the Prisma Health/USC School of Medicine Greenville Family Medicine Residency Program and Clinical Associate Professor at the University of South Carolina School of Medicine, GreenvilleAndrea Darby Stewart, MD, Associate Director, Honor Health Family Medicine Residency Program and Clinical Professor of Family, Community & Occupational Medicine at the University of Arizona College of Medicine - PhoenixCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science UniversityNone of the speakers have anything to disclose.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in January 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Chart: Managing Community-Acquired Pneumonia and Aspiration Pneumonia in AdultsFAQ: Antibiotic Therapy: When Are Shorter Courses Better?Chart: Managing Cough and Cold SymptomsSend us a textCheck out our NEW podcasts. Rumor vs TruthYour trusted source for facts... where we dissect the evidence behind risky rumors and reveal clinical truths.Clinical CapsulesTRC editors break down the most impactful clinical developments - giving you clear, actionable takeaways in just minutes.If you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Exclusão de Jonas Savimbi e Holden Roberto das homenagens nos 50 anos de independência de Angola é espelho da "narrativa dominante" do MPLA, diz analista. Em Moçambique, Daniel Chapo é candidato único à presidência da FRELIM, mas há entraves legais. Corrente anti-Ocidente deixa Europa mais longe das matérias-primas do Sahel.

Entre 10 e 15 de janeiro de 1975, representantes do MPLA, da UNITA e da FNLA negociaram a constituição de um governo de transição para a independência de Angola. Pouco depois, rebentava a guerra civilSee omnystudio.com/listener for privacy information.

Host: Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA A concerning number of patients with atherosclerotic cardiovascular disease (ASCVD) reached suboptimal LDL-C levels between 2021 and 2022. Even with new strategies that can help lower LDL-C, an analysis of over 3 million ASCVD patients in the Family Heart Database shows that these treatments are not being properly utilized. Join Dr. Keith C. Ferdinand as he delves into an analysis of management trends among these patients, which he presented at the 2024 Family Heart Foundation Global Summit. Dr. Ferdinand is a Professor of Medicine and the Gerald S. Berenson Endowed Chair in Preventative Cardiology at the Tulane University School of Medicine in New Orleans, Louisiana.

Host: Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA A concerning number of patients with atherosclerotic cardiovascular disease (ASCVD) reached suboptimal LDL-C levels between 2021 and 2022. Even with new strategies that can help lower LDL-C, an analysis of over 3 million ASCVD patients in the Family Heart Database shows that these treatments are not being properly utilized. Join Dr. Keith C. Ferdinand as he delves into an analysis of management trends among these patients, which he presented at the 2024 Family Heart Foundation Global Summit. Dr. Ferdinand is a Professor of Medicine and the Gerald S. Berenson Endowed Chair in Preventative Cardiology at the Tulane University School of Medicine in New Orleans, Louisiana.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/MRJ865. CME/MOC/NCPD/CPE/AAPA credit will be available until October 17, 2025.Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Family Heart Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/MRJ865. CME/MOC/NCPD/CPE/AAPA credit will be available until October 17, 2025.Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Family Heart Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/MRJ865. CME/MOC/NCPD/CPE/AAPA credit will be available until October 17, 2025.Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Family Heart Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/MRJ865. CME/MOC/NCPD/CPE/AAPA credit will be available until October 17, 2025.Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Family Heart Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/MRJ865. CME/MOC/NCPD/CPE/AAPA credit will be available until October 17, 2025.Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Family Heart Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/MRJ865. CME/MOC/NCPD/CPE/AAPA credit will be available until October 17, 2025.Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Family Heart Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/MRJ865. CME/MOC/NCPD/CPE/AAPA credit will be available until October 17, 2025.Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Family Heart Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/MRJ865. CME/MOC/NCPD/CPE/AAPA credit will be available until October 17, 2025.Changing the Future for Families With HoFH: Long-Term Benefits of Early Diagnosis and Treatment for Homozygous Familial Hypercholesterolemia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Family Heart Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

Special guest Lori A. Wilken, PharmD, FCCP, BCACP, NCTTP, AE-C, Clinical Assistant Professor in the Department of Pharmacy Practice at the University of Illinois, Chicago, joins us to talkabout Asthma and COPD treatment.Listen in as we discuss answers to your big questions about treatment of asthma and COPD. You'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Clinical Assistant Professor of Family Medicine, Prisma Health/USC-SOMG Family Medicine Residency Program at the USC School of Medicine GreenvilleAndrea Darby Stewart, MD, Associate Director, Honor Health Family Medicine Residency Program and Clinical Professor of Family, Community & Occupational Medicine at the University of Arizona College of Medicine - PhoenixCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science UniversityFor the purposes of disclosure, Dr. Wilken reports relevant financial relationships [pulmonary] with AstraZeneca/Simpson Healthcare, OptumRx. (consultant). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter and Prescriber Insights: Chart: Biologics and Inhalation Medications for AsthmaChart: Inhaled Medications for COPDIf you're not yet a Pharmacist's Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com. Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Terry Thomas, RN, MSN, FNLA, FPCNA, describes how nurses improve cardiovascular care with their implementation efforts. Whether new to your career, or more tenured in CVD prevention and management, you'll be inspired by Terry to continue to make a difference each day. PCNA ResourcesChapters: https://pcna.net/chapters/Membership: https://pcna.net/member-center/Clinical Resources & Tools: https://pcna.net/clinical-resources/Professional Development: https://pcna.net/professional-development/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, listen in as our expert panelists discuss tips for creating successful learning experiences for students and residents.  We'll review various teaching tools and summarize strategies for incorporating learners into your practice. We'll also discuss different approaches for providing meaningful feedback and managing challenging situations with learners.Our panel for this conversation includes: Andrea Darby Stewart, MD; Associate Director, Honor Health Family Medicine Residency Program; Clinical Professor of Family, Community & Occupational Medicine, University of Arizona College of Medicine – PhoenixMary Franks, MSN, APRN-FPA, FNP-C; Nurse Planner, NetCE; Adjunct Professor, Bradley University; Nurse Practitioner, Carle HealthMegan Smith, PharmD, BCACP; Associate Professor, College of Pharmacy, University of Arkansas for Medical Sciences (UAMS); Residency Program Director, UAMS Community-Based Residency ProgramCraig D. Williams, PharmD, FNLA, BCPS; Clinical Professor of Pharmacy Practice, Oregon Health and Science UniversityNone of the speakers have anything to disclose. TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter and Prescriber Insights: Toolbox: Preceptor's GuideFAQ: Prevention and Management of Burnout for Healthcare Professionals If you're not yet a Pharmacist's Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com. Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Special guest Marshall E. Cates, PharmD, BCPP, FASHP, FCCP, FALSHP, Professor of Pharmacy Practice from the McWhorter School of Pharmacy at Samford University joins us to talk about pharmacotherapy for anxiety and depression.Listen in as we discuss pharmacotherapy for managing generalized anxiety disorder and major depression, with a focus on tailoring first- or second-line options to individual patient needs.You'll also hear practical advice from Craig D. Williams, PharmD, FNLA, BCPS, a member of TRC's Editorial Advisory Board and Clinical Professor of Pharmacy Practice at the Oregon Health and Science University.For the purposes of disclosure, Dr. Cates reports relevant financial relationships [psychiatry] with Biogen, Sage Therapeutics (honorarium); Otsuka (speakers bureau).The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.The clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter and Prescriber Insights: Chart: Pharmacotherapy of Anxiety Disorders in AdultsChart: Choosing and Switching AntidepressantsChart: Combining and Augmenting AntidepressantsIf you're not yet a Pharmacist's Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com. Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Alan Brown, MD, FNLA talks with Christie Ballantyne, MD, FNLA about the publication of "A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice"

Featured panelist Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science University joins us to talk about diabetes treatment updates.Listen in as we discuss management of type 2 diabetes, including overcoming hurdles with metformin, GLP-1 agonists, and SGLT2 inhibitors.You'll also hear practical advice from a panelist on TRC's Editorial Advisory Board:Andrea Darby Stewart, MD, Associate Director, Honor Health Family Medicine Residency Program and Clinical Professor of Family, Community & Occupational Medicine at the University of Arizona College of Medicine - PhoenixNone of the speakers have anything to disclose. TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.The clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter and Prescriber Insights: Chart: Drugs for Type 2 DiabetesAlgorithm: Improving Tolerability to MetforminFAQ: Hyperglycemia in the HospitalIf you're not yet a Pharmacist's Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com. Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Treating inflammation in cardiovascular disease includes helping patients to understand the safety and efficacy of prescription and over-the-counter products. Joseph Saseen, Pharm D, FNLA, CLS discusses best practices in clinical decision-making, mechanisms of action , and guideline-based evidence for various anti-inflammatory medications.2023 AHA/ACC Guideline for the Management of Patients with Chronic Coronary Disease: https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000001168CANTOS trial: https://www.nejm.org/doi/full/10.1056/nejmoa1707914ACC guidelines & clinical documents: https://www.acc.org/GuidelinesICER (Institute for Clinical and Economic Review): https://icer.org/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Special guest Jennifer N. Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM,  Clinical Professor and Director of Pharmacy Education from the University of South Carolina College of Pharmacy joins us to talk about meds for obesity and weight loss.Listen in as they discuss management of overweight and obesity, including the role of newer injectable medications, oral options, and lifestyle changes.You'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Clinical Assistant Professor of Family Medicine, Prisma Health/USC-SOMG Family Medicine Residency Program at the USC School of Medicine GreenvilleAndrea Darby Stewart, MD, Associate Director, Honor Health Family Medicine Residency Program and Clinical Professor of Family, Community & Occupational Medicine at the University of Arizona College of Medicine - PhoenixCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science UniversityFor the purposes of disclosure, Dr. Clements reports relevant financial relationships [GLP-1 agonists] with Eli Lilly, Novo Nordisk (speakers bureau).TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.The clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter and Prescriber Insights: Chart: Weight Loss ProductsToolbox: Weight Loss: Helping Your Overweight and Obese PatientsIf you're not yet a Pharmacist's Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com. Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Após saída da CEDEAO, analistas afirmam que o Mali quer ter o controlo do seu destino nas prórpias mãos. Na Guiné-Bissau, Domingos Simões Pereira recusa legislativas antecipadas. Em Moçambique, ativista diz que há falta de transparência no processo de repatriamento de "Man Gena". E Lula da Silva voltou a adjetivar guerra em Gaza de genocídio

Special guest Sarah E. Stumbar, MD, MPH, Assistant Dean for Clinical Education, Office of Medical Education and Associate Professor of Family Medicine, Department of Medical Education from the Herbert Wertheim College of Medicine, Florida International University joins us to talk about oral contraceptives.Listen in as our expert panel discusses safety and efficacy of combined oral contraceptives and progestin-only pills.  They'll also prepare you to help patients navigate norgestrel tablets, the first over the counter daily oral contraceptive.You'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Clinical Assistant Professor of Family Medicine, Prisma Health/USC-SOMG Family Medicine Residency Program at the USC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science UniversityNone of the speakers have anything to disclose. TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.The clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter and Prescriber Insights: FAQ: Choosing a ContraceptiveChart: Comparison of Oral Contraceptives and Non-Oral Alternatives (United States)Chart: Comparison of Oral Contraceptives and Non-Oral Alternatives (Canada)If you're not yet a Pharmacist's Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com. Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars', for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts. To access other resources from the clinical leader in Obesity Medicine, please visit: www.obesitymedicine.org. In this three part series, Dr. Bays and Dr. Bindlish review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. Episode Guests Dr. Shagun Bindlish, MD Dr. Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Related Resources Obesity Pillars®

Heart Failure with Preserved Ejection Fraction (HFpEF) and Guideline/Consensus Document Writing Special Guest: Dave Dixon, PharmD, FACC, FAHA, FCCP, FNLA, BCACP, CDCES, CLS 02:57 – Experience and advice with guideline/consensus document writing  19:40 – HFpEF definition, complications, acute presentation, and HFpEF mimics 36:17 – HFpEF GDMT treatment 61:50 – Future directions and take-home points Reference List: https://pharmacytodose.files.wordpress.com/2023/08/hfpef-references.pdf PharmacyToDose.Com  @PharmacyToDose  PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars', for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts. To access other resources from the clinical leader in Obesity Medicine, please visit: www.obesitymedicine.org. In this three part series, Dr. Bays and Dr. Bindlish review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. Episode Guests Dr. Shagun Bindlish, MD Dr. Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Related Resources Obesity Pillars®

Alan Brown, MD, FNLA talks with Carol F. Kirkpatrick, PhD, MPH, RDN, CLS, FNLA and Kevin C Maki, PhD, CLS, FNLA, FTOS, FACN to discuss Nutrition Interventions for Adults with Dyslipidemia.